Further, elevated levels of PCNA and cyclin-D1 have been associated with more aggressive behavior in oral squamous cell carcinoma (OSCC), leading to multidrug resistance and exerting a detrimental effect on the prognosis and overall outcome of patients [24,25]. Here, PCNA is linked to oral cavity squamous cell carcinoma.